Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 405

1.

The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.

Miyake K, Higuchi T, Oshiro H, Zhang Z, Sugisawa N, Park JH, Razmjooei S, Katsuya Y, Barangi M, Li Y, Nelson SD, Murakami T, Homma Y, Hiroshima Y, Matsuyama R, Bouvet M, Chawla SP, Singh SR, Endo I, Hoffman RM.

Biomed Pharmacother. 2019 Jun 11;117:109093. doi: 10.1016/j.biopha.2019.109093. [Epub ahead of print]

PMID:
31200257
2.

RE: "Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection".

Bouvet M, Lwin TM, Hoffman RM.

Ann Surg. 2019 Jul;270(1):21-22. doi: 10.1097/SLA.0000000000003360. No abstract available.

PMID:
31188174
3.

Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model.

Oshiro H, Tome Y, Kiyuna T, Miyake K, Kawaguchi K, Higuchi T, Miyake M, Zang Z, Razmjooei S, Barangi M, Wangsiricharoen S, Nelson SD, Li Y, Bouvet M, Singh SR, Kanaya F, Hoffman RM.

Tissue Cell. 2019 Jun;58:17-23. doi: 10.1016/j.tice.2019.04.002. Epub 2019 Apr 3.

PMID:
31133242
4.

Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.

Hollandsworth HM, Lwin TM, Amirfakhri S, Filemoni F, Batra SK, Hoffman RM, Dhawan P, Bouvet M.

J Surg Res. 2019 May 8;242:145-150. doi: 10.1016/j.jss.2019.04.048. [Epub ahead of print]

PMID:
31077946
5.

Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model.

Higuchi T, Miyake K, Oshiro H, Sugisawa N, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Chawla SP, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Biochem Biophys Res Commun. 2019 May 28;513(2):326-331. doi: 10.1016/j.bbrc.2019.03.191. Epub 2019 Apr 5.

PMID:
30955860
6.

Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.

Miyake K, Murata T, Murakami T, Zhao M, Kiyuna T, Kawaguchi K, Igarashi K, Miyake M, Lwin TM, Hozumi C, Komatsu S, Kikuchi T, Bouvet M, Shimoya K, Singh SR, Endo I, Hoffman RM.

Arch Gynecol Obstet. 2019 Jun;299(6):1683-1690. doi: 10.1007/s00404-019-05147-3. Epub 2019 Apr 5.

PMID:
30953192
7.

The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model.

Higuchi T, Miyake K, Sugisawa N, Oshiro H, Zhang Z, Razmjooei S, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1075-1082. doi: 10.1007/s00280-019-03824-3. Epub 2019 Mar 30.

PMID:
30929053
8.

Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model.

Higuchi T, Miyake K, Sugisawa N, Oshiro H, Zhang Z, Razmjooei S, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Lett. 2019 Jun 1;451:122-127. doi: 10.1016/j.canlet.2019.03.003. Epub 2019 Mar 10.

PMID:
30867142
9.

Surgical and histological boundary of the hepatic hilar plate system: basic study relevant to surgery for hilar cholangiocarcinoma regarding the "true" proximal ductal margin.

Kikuchi Y, Matuyama R, Hiroshima Y, Murakami T, Bouvet M, Morioka D, Hoffman RM, Endo I.

J Hepatobiliary Pancreat Sci. 2019 May;26(5):159-168. doi: 10.1002/jhbp.617. Epub 2019 Mar 31.

PMID:
30825363
10.

Osimertinib Regresses an EGFR-Mutant Cisplatinum- Resistant Lung Adenocarcinoma Growing in the Brain in Nude Mice.

Higuchi T, Oshiro H, Zhang Z, Miyake K, Sugisawa N, Katsuya Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Zhao M, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Transl Oncol. 2019 Apr;12(4):640-645. doi: 10.1016/j.tranon.2019.01.007. Epub 2019 Feb 23.

11.

Low Conductive Electrodeposited Poly(2,5-dimethoxyaniline) as a Key Material in a Double Lateral Heterojunction, for Sub-ppm Ammonia Sensing in Humid Atmosphere.

Mateos M, Tchangaï MD, Meunier-Prest R, Heintz O, Herbst F, Suisse JM, Bouvet M.

ACS Sens. 2019 Mar 22;4(3):740-747. doi: 10.1021/acssensors.9b00109. Epub 2019 Feb 27.

PMID:
30773874
12.

Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model.

Miyake K, Kiyuna T, Kawaguchi K, Higuchi T, Oshiro H, Zhang Z, Wangsiricharoen S, Razmjooei S, Li Y, Nelson SD, Murakami T, Hiroshima Y, Matsuyama R, Bouvet M, Chawla SP, Singh SR, Endo I, Hoffman RM.

Cancer Chemother Pharmacol. 2019 May;83(5):809-815. doi: 10.1007/s00280-019-03782-w. Epub 2019 Feb 13.

PMID:
30758647
13.

Evaluation of treatment and outcomes for Hispanic patients with gastric cancer at Commission on Cancer-accredited centers in the United States.

Zhao B, Leichman LP, Horgan S, Bouvet M, Kelly KJ.

J Surg Oncol. 2019 Jun;119(7):941-947. doi: 10.1002/jso.25408. Epub 2019 Feb 11.

PMID:
30742314
14.

Parathyroid adenoma presenting with spontaneous cervical and anterior mediastinal hemorrhage: A case report.

Khan S, Choe CC, Shabaik A, Bouvet M.

Medicine (Baltimore). 2019 Feb;98(5):e14347. doi: 10.1097/MD.0000000000014347.

15.

Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model.

Miyake K, Kiyuna T, Li S, Han Q, Tan Y, Zhao M, Oshiro H, Kawaguchi K, Higuchi T, Zhang Z, Razmjooei S, Barangi M, Wangsiricharoen S, Murakami T, Singh AS, Li Y, Nelson SD, Eilber FC, Bouvet M, Hiroshima Y, Chishima T, Matsuyama R, Singh SR, Endo I, Hoffman RM.

Chemotherapy. 2018;63(5):278-283. doi: 10.1159/000495574. Epub 2019 Jan 23.

PMID:
30673664
16.

Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model.

Miyake K, Kiyuna T, Miyake M, Kawaguchi K, Zhang Z, Wangsiricharoen S, Razmjooei S, Oshiro H, Higuchi T, Li Y, Nelson SD, Murakami T, Hiroshima Y, Kumamoto T, Matsuyama R, Bouvet M, Singh SR, Chawla SP, Endo I, Hoffman RM.

Biochem Biophys Res Commun. 2019 Feb 19;509(4):1041-1046. doi: 10.1016/j.bbrc.2019.01.046. Epub 2019 Jan 16.

PMID:
30660363
17.

Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.

Lwin TM, Miyake K, Murakami T, DeLong JC, Amirfakhri S, Filemoni F, Yoon SN, Yazaki PJ, Shivley JE, Datnow B, Clary BM, Hoffman RM, Bouvet M.

Oncotarget. 2018 Dec 18;9(99):37333-37342. doi: 10.18632/oncotarget.26484. eCollection 2018 Dec 18.

18.

Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein.

Oshiro H, Kiyuna T, Tome Y, Miyake K, Kawaguchi K, Higuchi T, Miyake M, Zhang Z, Razmjooei S, Barangi M, Wangsiricharoen S, Nelson SD, Li Y, Bouvet M, Singh SR, Kanaya F, Hoffman RM.

Anticancer Res. 2019 Jan;39(1):81-85. doi: 10.21873/anticanres.13082.

PMID:
30591443
19.

Interplay Between Phosphorylation and O-GlcNAcylation of Sarcomeric Proteins in Ischemic Heart Failure.

Mercier T, Bouvet M, Dubois-Deruy E, Dechaumes A, Beseme O, Richard V, Mulder P, Pinet F.

Front Endocrinol (Lausanne). 2018 Oct 5;9:598. doi: 10.3389/fendo.2018.00598. eCollection 2018.

20.

ASO Author Reflections: Fluorescent Anti-CEA IR800 for Tumor Labeling.

Lwin TM, Bouvet M.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):970-971. doi: 10.1245/s10434-018-6905-8. Epub 2018 Oct 15. No abstract available.

PMID:
30324479
21.

Critical Consideration of Myxedema Coma in the Postoperative Setting: A Case Report.

Tran M, Vincent L, Ho G, Kelly K, Bouvet M, Meier A.

A A Pract. 2019 Feb 15;12(4):119-121. doi: 10.1213/XAA.0000000000000864.

PMID:
30169383
22.

Imaging the interaction of αv integrin-GFP in osteosarcoma cells with RFP-expressing host stromal cells and tumor-scaffold collagen in the primary and metastatic tumor microenvironment.

Tome Y, Kiyuna T, Uehara F, Bouvet M, Tsuchiya H, Kanaya F, Hoffman RM.

J Cell Biochem. 2019 Jan;120(1):283-289. doi: 10.1002/jcb.27353. Epub 2018 Aug 26.

PMID:
30145815
23.

Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Lwin TM, Hoffman RM, Bouvet M.

J Surg Oncol. 2018 Aug;118(2):253-264. doi: 10.1002/jso.25150. Epub 2018 Aug 6. Review.

PMID:
30080930
24.

Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations.

Miyake K, Kawaguchi K, Miyake M, Zhao M, Kiyuna T, Igarashi K, Zhang Z, Murakami T, Li Y, Nelson SD, Bouvet M, Elliott I, Russell TA, Singh AS, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Singh SR, Endo I, Eilber FC, Hoffman RM.

Heliyon. 2018 Jun 6;4(6):e00643. doi: 10.1016/j.heliyon.2018.e00643. eCollection 2018 Jun.

25.

Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.

Kawaguchi K, Miyake K, Zhao M, Kiyuna T, Igarashi K, Miyake M, Higuchi T, Oshiro H, Bouvet M, Unno M, Hoffman RM.

Cell Cycle. 2018;17(16):2019-2026. doi: 10.1080/15384101.2018.1480223. Epub 2018 Sep 19.

PMID:
29963961
26.

Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake M, Higuchi T, Oshiro H, Zhang Z, Razmjooei S, Wangsiricharoen S, Bouvet M, Singh SR, Unno M, Hoffman RM.

Cancer Lett. 2018 Sep 28;432:251-259. doi: 10.1016/j.canlet.2018.06.016. Epub 2018 Jun 18.

PMID:
29928962
27.

Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction.

Turkieh A, Fertin M, Bouvet M, Mulder P, Drobecq H, Lemesle G, Lamblin N, de Groote P, Porouchani S, Chwastyniak M, Beseme O, Amouyel P, Mouquet F, Balligand JL, Richard V, Bauters C, Pinet F.

Circ Heart Fail. 2018 Jun;11(6):e004838. doi: 10.1161/CIRCHEARTFAILURE.117.004838.

PMID:
29891738
28.

MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.

Kawaguchi K, Igarashi K, Miyake K, Lwin TM, Miyake M, Kiyuna T, Hwang HK, Murakami T, Delong JC, Singh SR, Clary B, Bouvet M, Unno M, Hoffman RM.

Tissue Cell. 2018 Jun;52:124-128. doi: 10.1016/j.tice.2018.05.003. Epub 2018 May 5.

PMID:
29857821
29.

The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.

Lwin TM, Hoffman RM, Bouvet M.

Expert Rev Anticancer Ther. 2018 Jul;18(7):651-662. doi: 10.1080/14737140.2018.1477593. Epub 2018 May 28. Review.

PMID:
29768067
30.

Comprehensive Study of Poly(2,3,5,6-tetrafluoroaniline): From Electrosynthesis to Heterojunctions and Ammonia Sensing.

Mateos M, Meunier-Prest R, Heintz O, Herbst F, Suisse JM, Bouvet M.

ACS Appl Mater Interfaces. 2018 Jun 13;10(23):19974-19986. doi: 10.1021/acsami.8b03601. Epub 2018 May 29.

PMID:
29737156
31.

RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.

Sato K, Mori R, Hiroshima Y, Oba MS, Matsuyama R, Bouvet M, Hoffman RM, Endo I.

J Surg Res. 2018 Jun;226:122-130. doi: 10.1016/j.jss.2017.11.009. Epub 2018 Feb 22.

PMID:
29661277
32.

Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Lwin TM, Higuchi T, Kiyuna T, Miyake M, Oshiro H, Bouvet M, Unno M, Hoffman RM.

Cell Cycle. 2018;17(7):868-873. doi: 10.1080/15384101.2018.1445907. Epub 2018 May 21.

33.

Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.

Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, Roy H, Scheuner M, Singh S, Vidyarthi G, White J.

Dig Dis Sci. 2018 May;63(5):1123-1138. doi: 10.1007/s10620-018-5000-0. Epub 2018 Mar 23. Review.

34.

Optical Fibre NO₂ Sensor Based on Lutetium Bisphthalocyanine in a Mesoporous Silica Matrix.

Debliquy M, Lahem D, Bueno-Martinez A, Caucheteur C, Bouvet M, Recloux I, Raskin JP, Olivier MG.

Sensors (Basel). 2018 Mar 1;18(3). pii: E740. doi: 10.3390/s18030740.

35.

Transcriptomic definition of molecular subgroups of small round cell sarcomas.

Watson S, Perrin V, Guillemot D, Reynaud S, Coindre JM, Karanian M, Guinebretière JM, Freneaux P, Le Loarer F, Bouvet M, Galmiche-Rolland L, Larousserie F, Longchampt E, Ranchere-Vince D, Pierron G, Delattre O, Tirode F.

J Pathol. 2018 May;245(1):29-40. doi: 10.1002/path.5053. Epub 2018 Mar 30.

PMID:
29431183
36.

Fluorescence-guided Surgery with Splenic Preservation Prevents Tumor Recurrence in an Orthotopic Nude-mouse Model of Human Pancreatic Cancer.

Hwang HK, Kang CM, Lee SH, Murakami T, Kiyuna T, Kim SH, Hoffman RM, Bouvet M.

Anticancer Res. 2018 Feb;38(2):665-670.

PMID:
29374688
37.

Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.

Lwin TM, Murakami T, Miyake K, Yazaki PJ, Shivley JE, Hoffman RM, Bouvet M.

Ann Surg Oncol. 2018 Apr;25(4):1079-1085. doi: 10.1245/s10434-018-6344-6. Epub 2018 Jan 25.

38.

The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapy.

Miyake K, Murakami T, Kiyuna T, Igarashi K, Kawaguchi K, Miyake M, Li Y, Nelson SD, Dry SM, Bouvet M, Elliott IA, Russell TA, Singh AS, Eckardt MA, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Endo I, Eilber FC, Hoffman RM.

Oncotarget. 2017 Sep 8;8(61):103129-103136. doi: 10.18632/oncotarget.20789. eCollection 2017 Nov 28.

39.

Splenectomy is associated with an aggressive tumor growth pattern and altered host immunity in an orthotopic syngeneic murine pancreatic cancer model.

Hwang HK, Murakami T, Kiyuna T, Kim SH, Lee SH, Kang CM, Hoffman RM, Bouvet M.

Oncotarget. 2017 Sep 28;8(51):88827-88834. doi: 10.18632/oncotarget.21331. eCollection 2017 Oct 24.

40.

Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism.

DeLong JC, Ward EP, Lwin TM, Brumund KT, Kelly KJ, Horgan S, Bouvet M.

Surgery. 2018 Feb;163(2):388-392. doi: 10.1016/j.surg.2017.08.018. Epub 2017 Nov 10.

PMID:
29129358
41.

The benefits and limitations of robotic assisted transhiatal esophagectomy for esophageal cancer.

DeLong JC, Kelly KJ, Jacobsen GR, Sandler BJ, Horgan S, Bouvet M.

J Vis Surg. 2016 Sep 8;2:156. doi: 10.21037/jovs.2016.09.01. eCollection 2016. Review.

42.

Regarding the applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.

Lwin TM, Hoffman RM, Bouvet M.

Transl Gastroenterol Hepatol. 2017 Sep 12;2:70. doi: 10.21037/tgh.2017.08.09. eCollection 2017. No abstract available.

43.

Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.

DeLong JC, Murakami T, Yazaki PJ, Hoffman RM, Bouvet M.

J Surg Res. 2017 Oct;218:139-143. doi: 10.1016/j.jss.2017.05.069.

44.

Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells.

Yaniz-Galende E, Roux M, Nadaud S, Mougenot N, Bouvet M, Claude O, Lebreton G, Blanc C, Pinet F, Atassi F, Perret C, Dierick F, Dussaud S, Leprince P, Trégouët DA, Marazzi G, Sassoon D, Hulot JS.

J Am Coll Cardiol. 2017 Aug 8;70(6):728-741. doi: 10.1016/j.jacc.2017.06.010.

45.

Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic-Cancer Orthotopic Mouse Model.

Murakami T, Hiroshima Y, Zhang Y, Zhao M, Kiyuna T, Hwang HK, Miyake K, Homma Y, Mori R, Matsuyama R, Chishima T, Ichikawa Y, Tanaka K, Bouvet M, Endo I, Hoffman RM.

J Cell Biochem. 2018 Jan;119(1):634-639. doi: 10.1002/jcb.26224. Epub 2017 Aug 11.

PMID:
28628234
46.

Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expression.

Murakami T, Homma Y, Matsuyama R, Mori R, Miyake K, Tanaka Y, Den K, Nagashima Y, Nakazawa M, Hiroshima Y, Ueda M, Tanaka K, Hoffman RM, Bouvet M, Endo I.

J Surg Oncol. 2017 Sep;116(3):416-426. doi: 10.1002/jso.24681. Epub 2017 Jun 12.

PMID:
28608409
47.

Humidity-enhanced sub-ppm sensitivity to ammonia of covalently functionalized single-wall carbon nanotube bundle layers.

Rigoni F, Freddi S, Pagliara S, Drera G, Sangaletti L, Suisse JM, Bouvet M, Malovichko AM, Emelianov AV, Bobrinetskiy II.

Nanotechnology. 2017 Jun 23;28(25):255502. doi: 10.1088/1361-6528/aa6da7. Epub 2017 May 31.

PMID:
28561009
48.

MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX).

Kawaguchi K, Igarashi K, Murakami T, Kiyuna T, Lwin TM, Hwang HK, Delong JC, Clary BM, Bouvet M, Unno M, Hoffman RM.

Oncotarget. 2017 Jul 18;8(29):47490-47496. doi: 10.18632/oncotarget.17667.

49.

Improving theranostics in pancreatic cancer.

King J, Bouvet M, Singh G, Williams J.

J Surg Oncol. 2017 Jul;116(1):104-113. doi: 10.1002/jso.24625. Epub 2017 May 17. Review.

50.

Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.

Murakami T, Hiroshima Y, Miyake K, Hwang HK, Kiyuna T, DeLong JC, Lwin TM, Matsuyama R, Mori R, Kumamoto T, Chishima T, Tanaka K, Ichikawa Y, Bouvet M, Endo I, Hoffman RM.

Cell Cycle. 2017 May 19;16(10):1008-1014. doi: 10.1080/15384101.2017.1315489. Epub 2017 Apr 25.

Supplemental Content

Loading ...
Support Center